Celestica (CLS) Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Celestica in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CLS shares.
View CLS analyst ratings or view top-rated stocks.

8 brokers have issued 1 year target prices for Celestica's shares. Their CLS share price forecasts range from $14.00 to $25.00. On average, they anticipate the company's stock price to reach $21.31 in the next twelve months. This suggests that the stock has a possible downside of 13.0%.
View analysts price targets for CLS or view top-rated stocks among Wall Street analysts.

Celestica's stock was trading at $11.27 on January 1st, 2023. Since then, CLS shares have increased by 117.4% and is now trading at $24.50.
View the best growth stocks for 2023 here.

Celestica saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,790,000 shares, an increase of 35.6% from the August 31st total of 1,320,000 shares. Based on an average daily volume of 1,560,000 shares, the short-interest ratio is currently 1.1 days. Approximately 1.6% of the company's stock are sold short.
View Celestica's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our CLS earnings forecast.

Celestica will be holding an earnings conference call on Thursday, October 26th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Celestica Inc. (NYSE:CLS) announced its quarterly earnings data on Wednesday, July, 26th. The technology company reported $0.55 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.07. The technology company earned $1.94 billion during the quarter, compared to analysts' expectations of $1.81 billion. Celestica had a trailing twelve-month return on equity of 15.54% and a net margin of 2.17%. The business's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.44 earnings per share.

iShares International Small Cap Equity Factor ETF holds 106,536 shares of CLS stock, representing 0.28% of its portfolio.

Celestica updated its FY 2024 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $2.48- for the period. The company issued revenue guidance of -.

94 employees have rated Celestica Chief Executive Officer Rob Mionis on Glassdoor.com. Rob Mionis has an approval rating of 63% among the company's employees. This puts Rob Mionis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Celestica investors own include Aurora Cannabis (ACB), Quantum (QTM), Ballard Power Systems (BLDP), Portland General Electric (POR), NVIDIA (NVDA), Shopify (SHOP), AT&T (T), Advanced Micro Devices (AMD), Walt Disney (DIS) and Freeport-McMoRan (FCX).

Celestica trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLS."

Shares of CLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLS stock can currently be purchased for approximately $24.50.

Celestica (NYSE:CLS) has a market capitalization of $2.92 billion and generates $7.74 billion in revenue each year. The technology company earns $145.50 million in net income (profit) each year or $1.38 on an earnings per share basis.

The company employs 26,324 workers across the globe.

Celestica's mailing address is 5140 YONGE STREET SUITE 1900, TORONTO A6, M2N 6L7. The official website for the company is www.celestica.com. The technology company can be reached via phone at (416) 448-5800, via email at clsir@celestica.com, or via fax at 416-448-2280.